Stocks-RVMD-REVOLUTION Medicines Inc

RVMD REVOLUTION Medicines Inc

21.52 -0.35 (-1.60%)
Invest
Invest

Overview

Prev Close21.52
Day's Range 20.79 - 21.92
52 Week Range 14.00 - 28.09
Average Volume (3m)831.55K
1-Year Return-19.58%
Beta1.1374
Market Cap1.91B
P/E Ratio
Revenue29.51M
EPS-3.1808
Dividend (Yield) (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.716/06/202229/08/202208/11/202218.0020.0022.0024.0026.00
Chart times in UTC
Industry Pharmaceuticals Other
CEO Mark A. Goldsmith, MD, PhD
Employees 188

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: REVOLUTION Medicines Inc's revenues decreased by 31.62% and amounted to 29.39M. Net income decreased by 72.98% to -187.09M. Net assets increased by 26.94% to 602.57M and EPS decreased from -1.66 to -2.57.
RVMD's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
69.10%
Net Profit Margin
-238.14%
Operating Margin
-829.62%
Return On Investment
-162.23%
12/21
03/22
06/22
09/22
Total Revenue
9.46M
7.58M
9.12M
3.36M
Gross Profit
7.4M
5.29M
6.78M
923K
Operating Income
-52.91M
-57.95M
-62.09M
N/A
Net Income
-52.68M
-57.65M
-61.22M
-73.33M